Interestingly, it has been shown that IGF-I immunoreactivity was seen in a subpopulation of GFAP-immunopositive astroglia in the temporal cortex of post-mortem AD brain, strengthening its neuroprotective role in case of AD [14]. This evidence concerns the gene GFAP and Alzheimer disease.